HomeDSGN • NASDAQ
add
Design Therapeutics Inc
Previous close
$5.01
Day range
$4.79 - $5.02
Year range
$2.25 - $7.77
Market cap
279.71M USD
Avg Volume
212.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.37M | -21.47% |
Net income | -13.04M | 17.42% |
Net profit margin | — | — |
Earnings per share | -0.23 | 17.86% |
EBITDA | -16.09M | 13.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 254.07M | -12.67% |
Total assets | 261.63M | -12.75% |
Total liabilities | 9.18M | -38.47% |
Total equity | 252.45M | — |
Shares outstanding | 56.62M | — |
Price to book | 1.12 | — |
Return on assets | -15.29% | — |
Return on capital | -15.65% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -13.04M | 17.42% |
Cash from operations | -9.55M | 34.32% |
Cash from investing | -5.83M | -138.16% |
Cash from financing | 1.00K | -92.31% |
Net change in cash | -15.37M | -2,163.22% |
Free cash flow | -5.19M | 41.47% |
About
Founded
2017
Headquarters
Website
Employees
54
